RxDoctor Payments DataLook up a doctor →

Gary Steven, MD

Allergy · Greenfield, WINPI 1972530699

Payments from drug & device makers

$5,160,921in general payments, 2019–2025

Across 1,762 payments — averaging $2929.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1.7M
  • Teva Pharmaceuticals USA, Inc.$686K
  • Novartis$371K
  • Cipla USA Inc.$272K
  • Amphastar Pharmaceuticals, Inc.$268K
  • Regeneron$249K
  • plus $1.6M from 41 others
$2,029in research payments, 2019–2025

Across 3 payments — averaging $676.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Chiesi USA, Inc.$2K

What the payments were for

  • Consulting fees$29,37119%
  • Speaking & faculty fees$87,74057%
  • Travel & lodging$10,6727%
  • Food & beverage$24,80816%
  • Education$2740%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few allergy providers in Wisconsinto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$150,214
Medicare patients
189
Services billed
5,830

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab34$158,318
Dupixent PenDupilumab22$113,676
XolairOmalizumab33$102,120
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$78,584
Arnuity ElliptaFluticasone Furoate124$49,385
Breztri AerosphereBudesonide/Glycopyr/Formoterol47$45,815
NucalaMepolizumab12$41,889
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr31$28,148
Spiriva HandihalerTiotropium Bromide27$26,315
Breo ElliptaFluticasone/Vilanterol46$26,169
SymbicortBudesonide/Formoterol Fumarate74$25,929
Advair HfaFluticasone Propion/Salmeterol30$19,962
Qvar RedihalerBeclomethasone Dipropionate47$18,832
Combivent RespimatIpratropium/Albuterol Sulfate22$17,944
Spiriva RespimatTiotropium Bromide21$15,694

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Arnuity Ellipta, Nucala, Anoro Ellipta, Breo Ellipta$159,448$224,175278 claims
Genentech, Inc.Xolair$219,900$102,12033 claims
AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler$1,729,405$78,465137 claims
Boehringer IngelheimCombivent Respimat, Spiriva Respimat$437$33,63843 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$685,544$18,83247 claims
MerckDulera, Asmanex$34,141$9,47432 claims
Hikma Pharmaceuticals USAEpinephrine$246,003$2,37812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Wisconsinon file to place this against a meaningful peer group, so we don't.

Other allergy in Greenfield

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →